Zymeworks, Inc. (ZYME)
30.02
-1.03
(-3.32%)
USD |
NASDAQ |
Sep 03, 11:00
Zymeworks Net Income (TTM) : -149.99M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -149.99M |
| March 31, 2026 | -102.66M |
| December 31, 2025 | -81.13M |
| September 30, 2025 | -63.43M |
| June 30, 2025 | -73.68M |
| March 31, 2025 | -113.68M |
| December 31, 2024 | -122.70M |
| September 30, 2024 | -113.67M |
| June 30, 2024 | -112.51M |
| March 31, 2024 | -125.97M |
| December 31, 2023 | -118.67M |
| September 30, 2023 | 205.24M |
| June 30, 2023 | 186.08M |
| March 31, 2023 | 172.61M |
| December 31, 2022 | 124.34M |
| September 30, 2022 | -224.24M |
| June 30, 2022 | -236.98M |
| March 31, 2022 | -239.88M |
| December 31, 2021 | -211.84M |
| September 30, 2021 | -210.58M |
| June 30, 2021 | -222.57M |
| March 31, 2021 | -194.01M |
| December 31, 2020 | -180.55M |
| September 30, 2020 | -214.90M |
| Date | Value |
|---|---|
| June 30, 2020 | -172.82M |
| March 31, 2020 | -162.93M |
| December 31, 2019 | -145.44M |
| September 30, 2019 | -63.92M |
| June 30, 2019 | -52.20M |
| March 31, 2019 | -28.99M |
| December 31, 2018 | -36.56M |
| September 30, 2018 | -13.10M |
| June 30, 2018 | -10.59M |
| March 31, 2018 | -15.68M |
| December 31, 2017 | -10.41M |
| September 30, 2017 | -54.42M |
| June 30, 2017 | -50.57M |
| March 31, 2017 | -47.02M |
| December 31, 2016 | -33.81M |
| September 30, 2016 | -30.48M |
| June 30, 2016 | -23.90M |
| March 31, 2016 | -20.99M |
| December 31, 2015 | -19.17M |
| September 30, 2015 | -14.44M |
| June 30, 2015 | -12.15M |
| March 31, 2015 | -11.08M |
| December 31, 2014 | -12.94M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Theravance Biopharma, Inc. | 53.81M |
| BridgeBio Pharma, Inc. | -702.02M |
| Aprea Therapeutics, Inc. | -12.31M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |